Strategies to Improve Asthma and Treatment of Asthma in Canadians
- Conditions
- Asthma
- Registration Number
- NCT01525381
- Lead Sponsor
- Ottawa Hospital Research Institute
- Brief Summary
Our study will enroll 644 randomly-selected Canadians who have been diagnosed with asthma by a physician within the previous five years. It will be determined what diagnostic tests were initially performed to make this diagnosis. Participants will undergo lung function testing over 6-8 weeks to determine their respiratory status and to confirm they have asthma. Participants may be followed up to one year depending on their test results.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 701
- Patient must have a recent diagnosis of asthma by a physician. Diagnosis of asthma must have occurred within 5 years prior to entry into the study.
- Patient must be at least 18 years old.
-
Patients in whom methacholine challenge is contraindicated
- Patients using chronic oral prednisone.
- Patients with heart attack or stroke within three previous months, and those with known aortic or cerebral aneurysms.
- Pregnant patients (unknown effect of methacholine on the fetus) and breastfeeding patients (unknown whether methacholine is excreted in breast milk).
-
Patients unable to provide informed consent.
-
Patients not able to perform spirometry and/or methacholine challenge testing.
-
Patients who have a greater than 10 pack-year smoking history (this will exclude patients with possible COPD).
-
Patients who currently have active pulmonary Tuberculosis
-
Patients who have had eye surgery in the past 3 months or who have a detached retina
-
Patients involved in another interventional asthma study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ottawa Hospital
🇨🇦Ottawa, Ontario, Canada